Anodyne| DCK | |
|---|---|
 |
| Salts [] | |
|---|---|
| Deschloroketamine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 203.28 g/mol [1] |
| Predicted LogP | 1.6 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H17NO [1] |
| IUPAC name | 2-(methylamino)-2-phenylcyclohexan-1-one [1] |
| SMILES | CNC1(CCCCC1=O)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C13H17NO/c1-14-13(10-6-5-9-12(13)15)11-7-3-2-4-8-11/h2-4,7-8,14H,5-6,9-10H2,1H3 [1] |
| InChIKey | ZAGBSZSITDFFAF-UHFFFAOYSA-N [1] |
Deschloroketamine
Deschloroketamine is a
Chemistry
Salts []
Deschloroketamine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Deschloroketamine is a racemic mixture of the enantiomers
Legal status []
- Canada: Deschloroketamine is a Schedule I substance.
- United Kingdom: Deschloroketamine is a Class B substance.
- Germany: Deschloroketamine is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 437168, Deschloroketamine. Accessed December 20, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/437168
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Deschloroketamine. UNII: B0J1D1S3EI. Global Substance Registration System. Accessed December 20, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/B0J1D1S3EI